U.N. says global fight against AIDS is at ‘precarious point’
By Kate Kelland LONDON (Reuters) – Complacency is starting to stall the fight against the...
Read More
Updated
Bill Gates backs $30 million push for early Alzheimer’s diagnostics
CHICAGO (Reuters) – Billionaire Bill Gates and Estée Lauder Cos chairman emeritus Leonard...
Read More
J&J beats quarterly expectations on drug sales surge, shares jump
By Manas Mishra (Reuters) – Johnson & Johnson on Tuesday reported better-than-expected...
Read More
UnitedHealth second quarter medical costs miss estimates, shares slide
By Caroline Humer and Tamara Mathias (Reuters) – UnitedHealth Group Inc, the largest U.S....
Read More
Roche touts new flu drug as Tamiflu suffers generics hit
ZURICH (Reuters) – Swiss drugmaker Roche’s hopes of recapturing lost ground in the...
Read More
Judge rules for Trump administration in suit over family-planning program shift
By Brendan O’Brien (Reuters) – A federal judge ruled on Monday against birth control...
Read More
Texas fetal tissue burial law on trial at U.S. court
By Jon Herskovitz AUSTIN, Texas (Reuters) – A court hearing on a Texas law requiring the...
Read More
Yes, it’s harder to sleep in the hospital
By Lisa Rapaport (Reuters Health) – Hospital patients get a lot less sleep, wake up more...
Read MoreCRISPR gene editing can cause risky collateral DNA damage: study
By Kate Kelland LONDON (Reuters) – Scientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause unexpected genetic damage which could lead to dangerous changes in...
Read More
Iowa, Illinois investigating infections linked to McDonald’s salad
(Reuters) – The Iowa and Illinois health departments said on Thursday that they were...
Read MoreIndivior wins preliminary injunction against generic rival
(Reuters) – A U.S. court has granted Indivior a preliminary injunction blocking India’s Dr. Reddy’s Laboratories from selling cut-price versions of the British drugmaker’s best-selling opioid addiction...
Read More
J&J vows to overturn $4.7 billion talc verdict but experts see hurdles
By Tina Bellon NEW YORK (Reuters) – Johnson & Johnson has vowed to appeal a $4.7 billion...
Read MoreU.S. court denies Jazz Pharma bid to revive narcolepsy drug patents
By Jan Wolfe (Reuters) – A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a...
Read More
Jury orders J&J to pay $4.7 billion in Missouri asbestos cancer case
By Tina Bellon (Reuters) – A Missouri jury on Thursday ordered Johnson & Johnson...
Read More
Zogenix’s seizure drug clears late-stage trial, shares soar
By Manas Mishra (Reuters) – Zogenix Inc <ZGNX.O> said on Thursday its drug to treat a...
Read More
Trump told Pfizer CEO price hikes hurt his drug plan: source
By Michael Erman and Yasmeen Abutaleb NEW YORK/WASHINGTON (Reuters) – U.S. President Donald...
Read More
Pfizer delays drug price hikes after talking with Trump
By Yasmeen Abutaleb and Michael Erman WASHINGTON/NEW YORK (Reuters) – Pfizer Inc...
Read More
Trump slams Pfizer after July 1 drug price hikes
By Michael Erman and Susan Heavey NEW YORK/WASHINGTON (Reuters) – U.S. President Donald...
Read MoreCTI Biopharma’s cancer drug fails late-stage trial, shares tumble
(Reuters) – CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the main goal of a late-stage trial, sending its shares down 17 percent. The drug, Pixuvri, did not show improvement in...
Read More
Insurers warn of rising premiums after Trump axes Obamacare payments again
By Amanda Becker and Carl O’Donnell WASHINGTON/NEW YORK (Reuters) – Health insurers...
Read More